Navigation Links
2012 Biotechnology and Pharmaceuticals: Forthcoming Conferences and Exhibitions
Date:1/19/2012

HARTFORD, Conn., Jan. 19, 2012 /PRNewswire-iReach/ -- Global Information Inc. (GII) is pleased to announce a series of forthcoming conferences and networking events in the pharmaceuticals and biotechnology focus areas. These international industry events provide a platform for researchers and decision makers in biotechnology and pharmaceuticals to present their latest findings and learn about significant developments in the biotechnology and pharmaceuticals industries. Conferences and exhibitions provide networking opportunities with leaders from all sectors of biotechnology and pharmaceuticals.

(Photo: http://photos.prnewswire.com/prnh/20120119/CG38721)

View the list of upcoming biotechnology and pharmaceuticals global industry events in 2012 or visit http://www.giiresearch.com/conference/partnering_lifescience.shtml

February 2012

Summit for Clinical Trials Operations Executives (SCOPE) | 7th February 2012 | Miami, Florida, USA

For more details visit: http://www.giiresearch.com/conference/chi201537-2012/

International Conference on Drug Discovery & Therapy | 12th February 2012 | Dubai, UAE

For more details visit:  http://www.giiresearch.com/conference/eur205073-2012/

Molecular Medicine Tri-Conference 2012 | 19th February 2012 | San Francisco, California, USA

For more deta
'/>"/>

SOURCE Global Information, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology news :

1. BGI enters agreement with National Center for Soybean Biotechnology to re-sequence 1,008 soybean lines
2. Exploiting Trichoderma: From food security to biotechnology
3. AAPS national biotechnology conference to highlight breakthrough cancer treatments
4. Advances in Optics for Biotechnology, Medicine and Surgery XII
5. Developments in nanobiotechnology at UCSB point to medical applications
6. Success with cisgenics in forestry offers new tools for biotechnology
7. Cutting-edge vaccine research to be showcased at AAPS National Biotechnology Conference
8. Biotherapeutic Innovations on Display at AAPS National Biotechnology Conference
9. AAPS immunogenicity training course to be offered prior to national biotechnology conference
10. NYU School of Medicine presents biomedical researchers Dart/NYU Biotechnology Achievement Awards
11. New edition of ASM Press biotechnology text announced
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2014)... , Dec. 10, 2014  That blood pressure plays a ... while. Hypertension – the medical term for high blood pressure ... 1800s, and the inflatable cuff that,s used in measuring blood ... mean there,s nothing new about hypertension, its triggers and its ... about the condition and the best ways to treat it. ...
(Date:12/10/2014)... Forest Baptist Medical Center today announced plans for a ... Funding for this $50 million capital project is part ... launched next summer. The medical education ... R.J. Reynolds Tobacco Company complex, adjacent to 525@vine in ... plans to be ready to welcome medical students in ...
(Date:12/5/2014)... Dec. 4, 2014 Increased emphasis on ... in new testing and inspection technologies. The convergence ... to a range of innovative test solutions. This ... Generation Y, which is generally more inclined towards ... product development strategies of test equipment vendors will ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4
... dominant natural process of new species formation and trigger ... in the journal PLoS ONE . The ... to 375 million years ago suggests that the planet,s ... meet a similar fate. Although Earth has experienced ...
... significant problem on highway embankments in New England. To ... with a grasslegume mixture that usually including red fescue, ... thrive in acidic, infertile soil. "A mixture of red ... stabilize the soil, but only the red fescue survives ...
... EL PASO, TX To conserve dwindling water ... municipal wastewater that has been extensively treated and deemed ... recycled water can be cost-effective and helps conserve the ... of bedding plants means income and jobs, commercial growers ...
Cached Biology News:What triggers mass extinctions? Study shows how invasive species stop new life 2What triggers mass extinctions? Study shows how invasive species stop new life 3Researchers discover potential solutions to New England roadside erosion 2Can bedding plants thrive with recyled water? 2
(Date:12/19/2014)... 18, 2014 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... of chronic pain, announced the results of its annual ... was a transformational year in Relmada,s history and it ... company," said Sergio Traversa , chief executive officer ... on key financial, human resource and clinical development objectives ...
(Date:12/17/2014)... December 16, 2014 “Never say, ... Philipps- Universität Marburg’s Department of Physics, advises young ... the newly released SPIE Women in Optics ... too shy to ask questions.” , In the ... and mathematics) occupations ranging from university professor and ...
(Date:12/17/2014)... Long Beach, CA (PRWEB) December 17, 2014 ... Technology, Inc. to provide a larger packaged waste water ... district in King Abdullah Economic City (KAEC). Two years ... for EMAAR’s Jeddah Gate Development, serving two residential towers ... plant capacity is over a quarter million gallons per ...
(Date:12/17/2014)... Gene synthesis and bioengineering company ... into a technology access and services agreement with ... proprietary protein engineering technology, known as “ProteinGPS®” to ... extremely excited that the global leader ADM has ... bioengineering technology has now been validated through many ...
Breaking Biology Technology:Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 2Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 3ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2
... July 8 iZumi Bio, Inc. and Pierian, Inc. ... company, iPierian, Inc. Building on the iZumi infrastructure and ... cellular reprogramming to change the paradigm of drug discovery. ... development of new therapeutics using induced pluripotent stem (iPS) ...
... TREK Diagnostic Systems, a Magellan Biosciences business and premier ... labs, has received clearance from the U.S. Food and ... of YeastOne susceptibility products. TREK will make the drug ... the plate that best meets their requirements. The custom ...
... Immunotec Receives NHPD/Health Canada Authorization to Begin a Study on, ... Isolate (Immunocal(R)) in, Combination with Physical Exercise ... Cytokine Levels in Elderly Persons: A Randomized, ... Immunotec Inc. (TSX-V: IMM) announced today that the Natural Health ...
Cached Biology Technology:iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming 2iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming 3iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming 4iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming 5iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming 6FDA Clears Caspofungin (Cancidas(R)) Susceptibility Testing for TREK Sensititre(R) YeastOne(R) in Vitro Diagnostics (IVD) Product Line 2FDA Clears Caspofungin (Cancidas(R)) Susceptibility Testing for TREK Sensititre(R) YeastOne(R) in Vitro Diagnostics (IVD) Product Line 32009: Immunotec announces important clinical research initiative: New study to be launched with the goal of improving the quality of the aging process 22009: Immunotec announces important clinical research initiative: New study to be launched with the goal of improving the quality of the aging process 3